Four years of monitoring antibiotic resistance in microorganisms from bacteremic patients

Journal of Chemotherapy

Volumn 19, Issue 6, 2007, Pages 665-669

  Blahova, Jana ^a   Kralikova, K ^a   Krcmery Sr , V ^a   Babalova, M ^a   Menkyna, R ^a   Glosova, L ^b   Knotkova, H ^c   Liskova, A ^d   Molokacova, M ^e   Vaculikova, A ^f   Bruckmayerova, D ^g   Rovny, I ^h  

^a SLOVAK MEDICAL UNIVERSITY   (Slovakia)

^b University Hospital Trencin   (Slovakia)

^c Martinska Fakultna Nemocnica   (Slovakia)

^d University Hospital Nitra   (Slovakia)

^e L PASTEUR UNIVERSITY HOSPITAL   (Slovakia)

^f UNIVERSITY HOSPITAL BRATISLAVA   (Slovakia)

^g Railway Hospital Bratislava   (Slovakia)

^h Public Health Office of the Slovak Republic   (Slovakia)

Author keywords

Antibiotic resistance; Bacteremia; Monitoring of antibiotic resistance

Indexed keywords

AMINOGLYCOSIDE DERIVATIVE; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CEFEPIME; CEFOTAXIME; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; COAGULASE; ERYTHROMYCIN; GENTAMICIN; MACROLIDE; MEROPENEM; OXACILLIN; QUINOLONE DERIVATIVE; TEICOPLANIN; VANCOMYCIN;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; ENTEROCOCCUS; HOSPITAL HYGIENE; HOSPITALIZATION; HUMAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; PATIENT MONITORING; PSEUDOMONAS AERUGINOSA; SEPSIS; STAPHYLOCOCCUS AUREUS;

EID: 38949212450     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2007.19.6.665     Document Type: Article

References (12)

1. MacDougall C, Polk RE. Antimicrobial stewardship programs in health care systems. Clin Microbiol Rev 2005; 18 (4): 638-56.
2. Blahova J, Kralikova K, Krcmery V Sr, Babalova M, Menkyna R, Glosova L, et al. Monitoring of antibiotic resistance in bacterial isolates from patients. J Chemother 2004; 16(3): 269-272.
3. Persson L, Strid H, Tidefelt U, Soderquist B. Phenotypic and genotypic characterization of coagulase-negative staphylococci isolated in blood cultures from patients with haematological malignancies. Eur J Clin Microbiol Infect Dis 2006; 25(5): 299-309.
4. Erbay A, Ergonul O, Stoddard GJ, Samore MH. Recurrent catheter-related bloodstream infections: Risk factors and outcome. Int J Infect Dis 2006; 10(5): 396-400.
5. Sader HS, Streit JM, Fritsche TR, Jones RN. Antimicrobial susceptibility of gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Programme (2002-2004). Clin Microbiol Infect 2006; 12(9): 844-852.
6. Jacoby GA, Munoz-Price LS. The new beta-lactamases. N Engl J Med 2005; 352(4): 380-391.
7. Corvee S, Poirel L, Decousser JW, Allouch PY, Drugeon H, Nordmann P. Emergence of carbapenem-hydrolysing metallo-beta-lactamase VIM-1 in Pseudomonas aeruginosa isolates in France. Clin Microbiol Infect 2006; 12(9): 941-942.
8. Poirel L, Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect. 2006; 12(9): 826-36.
9. van den Broek PJ, Arends J, Bernards AT, De Brauwer E, Mascini EM, van der Reijden TJ, et al. Epidemiology of multiple Acinetobacter outbreaks in The Netherlands during the period 1999-2001. Clin Microbiol Infect 2006; 12(9): 837-843.
10. Walsh TR, Toleman MA, Poirel L, Nordmann P. Metallo-beta-lactamases: the quiet before the storm? Clin Microbiol Rev 2005; 18(2): 306-325.
11. Berild D, Mohseni A, Diep LM, Jensenius M, Ringertz SH. Adjustment of antibiotic treatment according to the results of blood cultures leads to decreased antibiotic use and costs. J Antimicrob Chemother 2006; 57(2): 326-330.
12. Pournaras S, Markogiannakis A, Ikonomidis A, Kondyli L, Bethimouti K, Maniatis AN, et al. Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit. J Antimicrob Chemother. 2006; 57(3): 557-561.